Exosomes produced by stem cells may act as a mediator for the therapeutic actions of stem cells. Recent advancements in stem cell therapy have given hope to those with Parkinson’s. For instance, mesenchymal stem cell (MSC) therapy has been demonstrated in clinical studies to be helpful in reducing the symptoms of Parkinson’s Disease.
Exosomes could be beneficial in the treatment of people with neurodegenerative conditions because of their capacity to regulate regeneration processes within our bodies. The anti-inflammatory effects of exosomes may be accountable for at least some of the therapeutic success. This might be due to the capacity of exosome therapy to pass through the blood-brain barrier (BBB), where they stimulates neuron differentiation and growth while suppressing inflammatory pathways in the nerve cells.